EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL

Autor:	V Vardanega, W Rawlinson, S Francis-Graham, D Mezzio, LA Eddowes
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S379
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2dfec37f8112285797fb29b17c805399 https://doi.org/10.1016/j.jval.2022.04.481 Zobrazit plný text záznamu Full Text from ScienceDirect